Arcturus Therapeutics Inc, a leading company in RNA therapies for rare diseases, will present new data on the company’s LUNAR RNA therapeutic platform during the 2nd International mRNA Health Conference from November 11-12, 2014 in Cambridge, Mass.
LUNAR is a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, antisense, and microRNA oligotherapeutics. The new findings could eventually offer those with Cystic Fibrosis a novel therapy for treating the disease.
- Disorders & Diseases
- Public Health
- Products & Treatment
- Department Management